share_log

Canaccord Genuity Maintains Buy on Pulmonx, Lowers Price Target to $12

Canaccord Genuity Maintains Buy on Pulmonx, Lowers Price Target to $12

Canaccord Genuity 维持对Pulmonx的买入,将目标股价下调至12美元
Benzinga ·  2023/10/31 14:18

Canaccord Genuity analyst William Plovanic maintains Pulmonx (NASDAQ:LUNG) with a Buy and lowers the price target from $20 to $12.

Cancord Genuity分析师William Plovanic维持Pulmonx(纳斯达克:Long)的买入,并将目标价从20美元下调至12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发